Robert Eugene Grubbe, MD in Oxford, AL - Allergy & Immunology

Robert Eugene Grubbe, MD is a Allergy & Immunology physician based in Oxford, Alabama. Robert Eugene Grubbe is licensed to practice in Alabama (license number 18769) and his current practice location is 912 Snow St, Oxford, Alabama. He can be reached at his office (for appointments etc.) via phone at (256) 835-1909.

NPI number for Robert Eugene Grubbe is 1457346140 and his current mailing address is Po Box 7190, Oxford, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1457346140.

Contact Information

	Robert Eugene Grubbe, MD
	912 Snow St, Oxford, AL 36203-1214
	(256) 835-1909
	(256) 832-0057

Physician's Profile

Full Name	Robert Eugene Grubbe
Gender	Male
Speciality	Allergy & Immunology
Location	912 Snow St, Oxford, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1457346140
Provider Enumeration Date: 09/19/2005
Last Update Date: 01/12/2009

Medical Identifiers

Medical identifiers for Robert Eugene Grubbe such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1457346140	NPI	-	NPPES
000045597	Medicaid	AL
DN4865	Other	AL	RAILROAD MEDICARE
51045597	Other	AL	BLUECROSS AND BLUESHIELD

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207K00000X	Allergy & Immunology	18769 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert Eugene Grubbe is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert Eugene Grubbe, MD Po Box 7190, Oxford, AL 36203-7190 Ph: (256) 835-1909	Robert Eugene Grubbe, MD 912 Snow St, Oxford, AL 36203-1214 Ph: (256) 835-1909

News Archive

Aromatase inhibitors raise risk of cardiovascular disease in postmenopausal breast cancer patients

Postmenopausal women who take aromatase inhibitors as a treatment for breast cancer may be at an increased risk for developing cardiovascular disease, according to the results of a meta-analysis.

Study describes the first known mutation to occur in lung cancer patients who have never smoked

Lung cancer patients who have never smoked are more likely than smokers to harbor one of two genetic mutations that researchers at UT Southwestern Medical Center have now linked to the disease.

Oral cladribine to be the first oral disease-modifying multiple sclerosis therapy despite receiving RTF letter

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.

Thirteen scientists receive grant to identify new treatments, cure for psoriasis

Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis—an autoimmune disease that appears on the skin, affecting 7.5 million Americans—and psoriatic arthritis—an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis.

Robert Eugene Grubbe, MD - Allergy & Immunology in Oxford, AL